Ncs2* mediates in vivo virulence of pathogenic yeast through sulphur modification of cytoplasmic transfer RNA

By Fiona Alings, Karin Scharmann, Cristian Eggers, Bettina Böttcher, Mikołaj Sokołowski, Ekaterina Shvetsova, Puneet Sharma, Joël Roth, Leon Rashiti, Sebastian Glatt, Sascha Brunke, Sebastian A Leidel

July 18, 2023

Abstract

Fungal pathogens threaten ecosystems and human health. Understanding the molecular basis of their virulence is key to develop new treatment strategies. Here, we characterize NCS2*, a point mutation identified in a clinical baker’s yeast isolate. Ncs2 is essential for 2-thiolation of tRNA and the NCS2* mutation leads to increased thiolation at body temperature. NCS2* yeast exhibits enhanced fitness when grown at elevated temperatures or when exposed to oxidative stress, inhibition of nutrient signalling, and cell-wall stress. Importantly, Ncs2* alters the interaction and stability of the thiolase complex likely mediated by nucleotide binding. The absence of 2-thiolation abrogates the in vivo virulence of pathogenic baker’s yeast in infected mice. Finally, hypomodification triggers changes in colony morphology and hyphae formation in the common commensal pathogen Candida albicans resulting in decreased virulence in a human cell culture model. These findings demonstrate that 2-thiolation of tRNA acts as a key mediator of fungal virulence and reveal new mechanistic insights into the function of the highly conserved tRNA-thiolase complex.

Posted on:
July 18, 2023
Length:
1 minute read, 165 words
Tags:
Ribosome profiling tRNA modification Pathogenic yeast NCS2
See Also:
Humans and other commonly used model organisms are resistant to cycloheximide-mediated biases in ribosome profiling experiments
Dual randomization of oligonucleotides to reduce the bias in ribosome-profiling libraries